VT
ONC icon

Vise Technologies’s BeOne Medicines Ltd ONC Stock Holding History

Vise Technologies’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$326K Buy
1,145
+221
+24% +$65.1K ﹤0.01% 1400
2026
Q1 		$281K Hold
924
– – 0.01% 1182
2025
Q4 		$281K Buy
924
+144
+18% +$47.1K 0.01% 1190
2025
Q3 		$266K Buy
+780
New +$237K 0.01% 968
2024
Q4 		$249K Buy
+1,346
New +$275K 0.02% 683

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vise Technologies's ONC Position: Q2 2026 in Review

Vise Technologies increased its BeOne Medicines Ltd (ONC) stake by 24% in Q2 2026, buying an estimated $65.1K and bringing the position to 1,145 shares worth $326K. The position accounts for ﹤0.01% of the portfolio, ranked #1400.

Vise Technologies first reported a position in ONC in Q4 2024 and has held it in 5 quarters since. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Vise Technologies held 1,145 shares of BeOne Medicines Ltd worth $326K as of Q2 2026.
  • Vise Technologies bought 221 BeOne Medicines Ltd shares in Q2 2026, an estimated $65.1K.
  • BeOne Medicines Ltd made up ﹤0.01% of Vise Technologies's portfolio in Q2 2026, its #1400 holding.
  • Vise Technologies first reported a position in BeOne Medicines Ltd in Q4 2024 and has held it in 5 quarters since.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.